322 related articles for article (PubMed ID: 15361834)
1. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
Unoki M; Nishidate T; Nakamura Y
Oncogene; 2004 Oct; 23(46):7601-10. PubMed ID: 15361834
[TBL] [Abstract][Full Text] [Related]
2. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
Abbady AQ; Bronner C; Bathami K; Muller CD; Jeanblanc M; Mathieu E; Klein JP; Candolfi E; Mousli M
Biochem Pharmacol; 2005 Aug; 70(4):570-9. PubMed ID: 15964557
[TBL] [Abstract][Full Text] [Related]
3. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
[TBL] [Abstract][Full Text] [Related]
4. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression.
Achour M; Jacq X; Rondé P; Alhosin M; Charlot C; Chataigneau T; Jeanblanc M; Macaluso M; Giordano A; Hughes AD; Schini-Kerth VB; Bronner C
Oncogene; 2008 Apr; 27(15):2187-97. PubMed ID: 17934516
[TBL] [Abstract][Full Text] [Related]
5. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein.
Nicolas E; Ait-Si-Ali S; Trouche D
Nucleic Acids Res; 2001 Aug; 29(15):3131-6. PubMed ID: 11470869
[TBL] [Abstract][Full Text] [Related]
7. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.
Zhang Y; Woodford N; Xia X; Hamburger AW
Nucleic Acids Res; 2003 Apr; 31(8):2168-77. PubMed ID: 12682367
[TBL] [Abstract][Full Text] [Related]
8. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
Magnaghi-Jaulin L; Groisman R; Naguibneva I; Robin P; Lorain S; Le Villain JP; Troalen F; Trouche D; Harel-Bellan A
Nature; 1998 Feb; 391(6667):601-5. PubMed ID: 9468140
[TBL] [Abstract][Full Text] [Related]
10. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
[TBL] [Abstract][Full Text] [Related]
11. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
[TBL] [Abstract][Full Text] [Related]
12. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).
Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P
Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525
[TBL] [Abstract][Full Text] [Related]
13. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
[TBL] [Abstract][Full Text] [Related]
14. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
15. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
16. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation.
Karagianni P; Amazit L; Qin J; Wong J
Mol Cell Biol; 2008 Jan; 28(2):705-17. PubMed ID: 17967883
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma protein recruits histone deacetylase to repress transcription.
Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
[TBL] [Abstract][Full Text] [Related]
18. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
19. A concern regarding the current confusion with the human homolog of mouse Np95, ICBP90/UHRF1.
Unoki M; Bronner C; Mousli M
Radiat Res; 2008 Feb; 169(2):240-4. PubMed ID: 18220474
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
Trotzier MA; Bronner C; Bathami K; Mathieu E; Abbady AQ; Jeanblanc M; Muller CD; Rochette-Egly C; Mousli M
Biochem Biophys Res Commun; 2004 Jun; 319(2):590-5. PubMed ID: 15178447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
